Battelle/BIO State Bioscience Initiatives 2010
The bioscience sector has continued to create jobs even in the midst of recession, Battelle/BIO finds in its annual State Bioscience Initiatives report.
12/14/2010
"Not every biotech company made it through the storm. Fifty publicly traded companies went bankrupt for lack of access to capital. But there is much good news. Biotech stocks outperformed virtually every other index in the first quarter of this year. The markets have come back but Biotech has come back faster and stronger," said Jim Greenwood, president and CEO of BIO.
While total private sector employment dropped 0.7 percent from 2007-2008, bioscience employment grew by 1.4 percent. Research, testing, and medical laboratories account for more than 176,000 jobs added from 2001-2008, representing nine of 10 new bioscience jobs created during that time.
States are taking advantage of this growth by investing in major bioscience initiatives; focusing on agricultural biotech and bioenergy; and implementing tax programs favorable to bio companies.
Project Announcements
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Aerowerks Plans Gaffney, South Carolina, Manufacturing Operations
05/04/2025
Sweden-Based Troax Group Plans Portland, Tennessee, Manufacturing Operations
05/04/2025
Kimberly-Clark Corporation Plans Warren, Ohio, Manufacturing Operations
05/04/2025
Denmark-Based Novonesis Expands Salem, Virginia, Production Operations
05/04/2025
Polyvlies USA Expands Winston-Salem, North Carolina, Manufacturing Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024